Christopher A Tam1, Brian T Helfand2, Bradley A Erickson3. 1. University of Iowa Carver College of Medicine, Iowa City, IA. 2. Northshore University Health System, Chicago, IL. 3. University of Iowa Carver College of Medicine, Iowa City, IA. Electronic address: brad-erickson@uiowa.edu.
Abstract
OBJECTIVE: To characterize the associations between diabetes mellitus (DM) and lower urinary tract symptoms (LUTS). This study focuses on the relationships between specific diabetic characteristics (eg, severity, biomarkers) and the prevalence of LUTS. MATERIALS AND METHODS: The 2005-2008 cycles of the National Health and Nutrition Examination Survey were queried for men who completed both a DM and a kidney/prostate questionnaire. Men with LUTS were defined as those experiencing at least 1 out of 3 of the following: nocturia, hesitancy, or incomplete emptying. Men with DM were defined as having been diagnosed by a physician and being actively treated. Multivariate logistic regression with sample weighting was performed to assess effects of biomarker levels (HgbA1c, fasting glucose), medication use, and surrogates of disease progression on the presence of LUTS. RESULTS: Of the 2127 male participants, those with DM (n = 405) were more likely to experience at least 1 urinary symptom (adjusted odds ratio 1.63, P <.0001). Men under the age of 70 with long-standing (>5 years) DM were more likely to report LUTS than those with a shorter duration of the disease (<5 years). Diabetes-specific biomarkers (HgbA1c, fasting glucose) were not predictors of LUTS in men with DM. CONCLUSION: DM was confirmed to be strongly associated with patient-reported LUTS in men. Younger men and those with longer-standing disease appear to be most susceptible. In actively treated patients with DM, DM biomarkers were not helpful in predicting individual LUTS. Instead, biomarkers that indirectly reflect DM disease progression were most useful. Published by Elsevier Inc.
OBJECTIVE: To characterize the associations between diabetes mellitus (DM) and lower urinary tract symptoms (LUTS). This study focuses on the relationships between specific diabetic characteristics (eg, severity, biomarkers) and the prevalence of LUTS. MATERIALS AND METHODS: The 2005-2008 cycles of the National Health and Nutrition Examination Survey were queried for men who completed both a DM and a kidney/prostate questionnaire. Men with LUTS were defined as those experiencing at least 1 out of 3 of the following: nocturia, hesitancy, or incomplete emptying. Men with DM were defined as having been diagnosed by a physician and being actively treated. Multivariate logistic regression with sample weighting was performed to assess effects of biomarker levels (HgbA1c, fasting glucose), medication use, and surrogates of disease progression on the presence of LUTS. RESULTS: Of the 2127 male participants, those with DM (n = 405) were more likely to experience at least 1 urinary symptom (adjusted odds ratio 1.63, P <.0001). Men under the age of 70 with long-standing (>5 years) DM were more likely to report LUTS than those with a shorter duration of the disease (<5 years). Diabetes-specific biomarkers (HgbA1c, fasting glucose) were not predictors of LUTS in men with DM. CONCLUSION:DM was confirmed to be strongly associated with patient-reported LUTS in men. Younger men and those with longer-standing disease appear to be most susceptible. In actively treated patients with DM, DM biomarkers were not helpful in predicting individual LUTS. Instead, biomarkers that indirectly reflect DM disease progression were most useful. Published by Elsevier Inc.
Authors: Paul F Pinsky; Barnett S Kramer; E David Crawford; Robert L Grubb; Donald A Urban; Gerald L Andriole; David Chia; David L Levin; John K Gohagan Journal: Urology Date: 2006-08 Impact factor: 2.649
Authors: Varant Kupelian; John T Wei; Michael P O'Leary; John W Kusek; Heather J Litman; Carol L Link; John B McKinlay Journal: Arch Intern Med Date: 2006-11-27
Authors: Aruna V Sarma; James P Burke; Debra J Jacobson; Michaela E McGree; Jennifer St Sauver; Cynthia J Girman; Michael M Lieber; William Herman; Jill Macoska; James E Montie; Steven J Jacobsen Journal: Diabetes Care Date: 2007-12-10 Impact factor: 19.112
Authors: Elbert S Huang; Sydney E S Brown; Bernard G Ewigman; Edward C Foley; David O Meltzer Journal: Diabetes Care Date: 2007-07-10 Impact factor: 19.112
Authors: Aruna V Sarma; Alka M Kanaya; Leroy M Nyberg; John W Kusek; Eric Vittinghoff; Brandy Rutledge; Patricia A Cleary; Patricia Gatcomb; Jeanette S Brown Journal: J Urol Date: 2009-01-18 Impact factor: 7.450
Authors: Maryellen S Kelly; Jonathan C Routh; Leah G Davis; J Todd Purves; John S Wiener; Matthew L Maciejewski Journal: Clin Pediatr (Phila) Date: 2018-08-27 Impact factor: 1.168
Authors: Faris Abushamma; Narjis Nassar; Sulafa Omar Najjar; Sobhe Mahmoud Hijaze; Amer Koni; Sa'ed H Zyoud; Amir Aghbar; Rifat Hanbali; Hashim Hashim Journal: Int J Gen Med Date: 2021-11-18